Relationship between serum levels of tumour necrosis factor-related apoptosis-inducing ligand and the survival of Chinese peritoneal dialysis patients

Nephrology

Volumn 17, Issue 5, 2012, Pages 466-471

  Poon, Peter Yam Kau ^a   Szeto, Cheuk Chun ^a   Kwan, Bonnie Ching Ha ^a   Chow, Kai Ming ^a   Leung, Chi Bon ^a   Li, Philip Kam Tao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

cardiovascular disease; inflammation; renal failure

Indexed keywords

TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADULT; ARTICLE; BLOOD LEVEL; CHINESE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PREDICTOR VARIABLE; PRIORITY JOURNAL; SURVIVAL;

ADULT; AGED; ARTERIES; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERITONEAL DIALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULSATILE FLOW; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UP-REGULATION;

EID: 84862999372     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2012.01605.x     Document Type: Article

References (33)

1. Yu AWY, Chau KF, Ho YW, Li PKT,. Development of the 'peritoneal dialysis first' model in Hong Kong. Perit. Dial. Int. 2007; 27 (Suppl 2): S53-5.
2. Li PKT, Szeto CC,. Success of the peritoneal dialysis programme in Hong Kong. Nephrol. Dial. Transplant. 2008; 23: 1475147-8.
3. Chan TM, Yung S,. Studying the effects of new peritoneal dialysis solutions on the peritoneum. Perit. Dial. Int. 2007; 27 (Suppl 2): S87-93. (Pubitemid 350047683)
4. Ducloux D, Bresson-Vautrin C, Kribs M, Abdelfatah A, Chalopin JM,. C-reactive protein and cardiovascular disease in peritoneal dialysis patients. Kidney Int. 2002; 62: 1417-22.
5. Choi HY, Lee JE, Han SH, et al,. Association of inflammation and protein-energy wasting with endothelial dysfunction in peritoneal dialysis patients. Nephrol. Dial. Transplant. 2010; 25: 1266-71.
6. Li PKT, Chow KM,. The Clinical and epidemiological aspects of vascular mortality in chronic peritoneal dialysis patients. Perit. Dial. Int. 2005; 25 (Suppl 3): S80-83. (Pubitemid 40883223)
7. Wiley SR, Schooley K, Smolak PJ, et al,. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3: 673-82. (Pubitemid 26091143)
8. Thorburn A,. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway signaling. J. Thorac. Oncol. 2007; 2: 461-5. (Pubitemid 47171799)
9. Mariani SM, Krammer PH,. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage. Eur. J. Immunol. 1998; 28: 973-82. (Pubitemid 28116210)
10. Zauli G, Secchiero P,. The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology. Cytokine Growth Factor Rev. 2006; 17: 245-57. (Pubitemid 44038614)
11. Zauli G, Pandolfi A, Gonelli A, et al,. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. Circ. Res. 2003; 92: 732-40. (Pubitemid 36457637)
12. Secchiero P, Corallini F, di Iasio MG, Gonelli A, Barbarotto E, Zauli G,. TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release. Blood 2005; 105: 3413-9. (Pubitemid 40628180)
13. Secchiero P, Candido R, Corallini F, et al,. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice. Circulation 2006; 114: 1522-30. (Pubitemid 44527008)
14. Michowitz Y, Goldstein E, Roth A, et al,. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis. J. Am. Coll. Cardiol. 2005; 45: 1018-24. (Pubitemid 40432432)
15. Mori K, Ikari Y, Jono S, et al,. Association of serum TRAIL level with coronary artery disease. Thromb. Res. 2010; 125: 322-5.
16. Volpato S, Ferrucci L, Secchiero P, et al,. Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults. Atherosclerosis 2011; 215: 452-8.
17. Weber T, Auer J, O'Rourke MF, et al,. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004; 109: 184-9. (Pubitemid 38114137)
18. Liabeuf S, Barreto DV, Barreto FC, et al,. The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients. Nephrol. Dial. Transplant. 2010; 25: 2596-602.
19. Chobanian AV, Bakris GL, Black HR, et al,. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206-52. (Pubitemid 37553153)
20. CANADA-USA (CANUSA) peritoneal dialysis study group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J. Am. Soc. Nephrol. 1996; 7: 198-207.
21. Covic A, Goldsmith DJ, Florea L, Gusbeth-Tatomir P, Covic M,. The influence of dialytic modality on arterial stiffness, pulse wave reflections, and vasomotor function. Perit. Dial. Int. 2004; 24: 365-72. (Pubitemid 39206632)
22. Gao N, Kwan BC, Chow KM, et al,. Arterial pulse wave velocity and peritoneal transport characteristics independently predict hospitalization in Chinese peritoneal dialysis patients. Perit. Dial. Int. 2010; 30: 80-5.
23. Szeto CC, Wong TY, Leung CB, et al,. Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int. 2000; 58: 400-7.
24. Chan JY, Che KI, Lam KM, et al,. Comprehensive malnutrition inflammation score as a marker of nutritional status in Chinese peritoneal dialysis patients. Nephrology (Carlton) 2007; 12: 130-4. (Pubitemid 46426845)
25. Szeto CC, Kwan BC, Chow KM, Leung CB, Law MC, Li PK,. Prognostic value of arterial pulse wave velocity in peritoneal dialysis patients. Am. J. Nephrol. 2012; 35: 127-33.
26. Kuragano T, Itoh K, Shimonaka Y, et al,. Hepcidin as well as TNF-α are significant predictors of arterial stiffness in patients on maintenance hemodialysis. Nephrol. Dial. Transplant. 2011; 26: 2663-7.
27. Angel K, Provan SA, Gulseth HL, Mowinckel P, Kvien TK, Atar D,. Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: A controlled study. Hypertension 2010; 55: 333-8.
28. Lo WK,. Serum parameters, inflammation, renal function and patient outcome. Contrib. Nephrol. 2006; 150: 152-5.
29. de Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, Dekker FW, Netherlands Cooperative Study on the Adequacy of Dialysis-II Study Group. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J. Ren. Nutr. 2009; 19: 127-35.
30. Leinig CE, Moraes T, Ribeiro S, et al,. Predictive value of malnutrition markers for mortality in peritoneal dialysis patients. J. Ren. Nutr. 2011; 21: 176-83.
31. Mehrotra R, Duong U, Jiwakanon S, et al,. Serum albumin as a predictor of mortality in peritoneal dialysis: Comparisons with hemodialysis. Am. J. Kidney Dis. 2011; 58: 418-28.
32. Fouque D, Kalantar-Zadeh K, Kopple J, et al,. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008; 73: 391-8. (Pubitemid 351186278)
33. Watt V, Chamberlain J, Steiner T, Francis S, Crossman D,. TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice. Atherosclerosis 2011; 215: 348-54.